5Yamaguchi K, Katayama H, Takashima T, et al. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology, 1991, 178:363-367.
6Widmark JM. Imaging-related medications: a class overview. Proc (Bayl Univ Med Cent), 2007, 20:408-417.
7Thomsen HS, Morcos SK. Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Badiol, 2006,16:1835-1840.
8Al Ghonaim M, Pannu N. Prevention and treatment of contrastinduced nephropathy. Tech Vase lnterv Radiol, 2006, 9:42-49.
9McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol, 2006, 98 :SK-13K.
10McCuUough P. Outcomes of contrast-induced nephropathy: experience in patientsundergoing cardiovascular intervention. Catheter Cardiovasc lnterv, 2006, 67:335-343.
2Marenzi G,Assanelli E,Campodonico J.Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality[J].Ann Inter Med,2009,150(3):215.
